The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat

Psychopharmacology

Volumn 140, Issue 3, 1998, Pages 371-377

  Malin, David H ^a   Lake, J Ronald ^a   Shenoi, Merle ^a   Upchurch, Timothy P ^a   Johnson, Shun C ^a   Schweinle, Will E ^a   Cadle, Chris D ^a  

^a UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

Author keywords

D Arginine; D NNA; L Arginine; Nicotine dependence; Nitric oxide synthase; NOS

Indexed keywords

DEXTRO ARGININE; DRUG VEHICLE; MECAMYLAMINE; N(G) NITROARGININE; NICOTINE TARTRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; ENZYME ACTIVITY; MALE; NONHUMAN; OPIATE ADDICTION; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SMOKING CESSATION; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ANIMALS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 0031798709     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050778     Document Type: Article

References (57)

1. G-nitro-L-arginine methyl ester. Life Sci 52: PL245-249
2. Adams ML, Sewing BN, Chen J, Meyer ER, Cicero TJ (1995) Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19:195-199
3. Bhargava HN (1995) Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol 26:1049-1053
4. Bhargava HN, Thorat SN (1996) Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology 52:86-91
5. Bredt DS, Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685
6. Bredt S, Glatt CE, Hwang PM, Fotuji M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624
7. Cappendijk SLT, de Vries R, Dzoljic MR (1993) Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone precipitated withdrawal syndrome in morphine dependent mice. Neurosci Lett 162:97-100
8. Carboni EG, Giua C, Di Chiara G (1996) Changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats are dissociated from physical abstinence syndrome. Soc Neurosci Abstr 22:164
9. G-nitro-arginine of endotoxin-induced hypotension and vascular hyporesponsiveness. J Cardiovasc Pharmacol 28:75-81
10. Dambisya YM, Lee T-L (1996) Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 117:914-918
11. Day MD (1979) Autonomic pharmacology: experimental and clinical aspects. Churchill Livingston, New York
12. Gilbert DG, Meliska CJ, Williams CL, Jensen RA (1992) Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 106: 275-281
13. Hatsukami DK, Hughes JR, Pickens RW, Svikis D (1984) Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology 84:231-326
14. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99-111
15. Hexum TD, Russett LR (1987) Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig. Brain Res 406:370-372
16. Hildebrand BE, Nomikos GG, Bondjers C, Nisell M, Svensson TH (1997) Behavioral manifestations of nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology 129:348-356
17. Jensen RA, Gilbert DG, Meliska CJ, Landrom TA, Szary AB (1990) Characterization of a dose response curve for nicotine induced conditioned taste aversion in rats: relationship to elevation of plasma β-endorphin concentration. Behav Neural Biol 53: 428-440
18. Kawabata A, Umeda N, Takagi H (1993) L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 109:73-79
19. Kimes AS, Vaupel DB, London ED (1993) Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 112:521-524
20. Kimes AS, Vaupel DB, London ED (1994) Comparison of the attenuation of the opioid withdrawal syndrome by 7-nitroindazole, a brain-specific nitric oxide synthase inhibitor, with that of other nitric oxide synthase inhibitors. Soc Neurosci Abstr 20:1675
21. Knowles RG, Palacios M, Palmer RMJ, Moncada S (1990) Nitric oxide synthase in the brain. In: Moncada S, Higgs EA (eds) Nitric oxide from L-arginine: a bioregulatory system. Elsevier, New York, pp 139-146
22. G-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221: 399-400
23. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW (1993) Blockade of tolerance to morphine hut not to κ opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166
24. Koob GF, Maldonado F, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191
25. Lake JR, Hammond MV, Shaddox RC, Hunsicker LM, Yang H-YT, Malin DH (1991) IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132: 29-32
26. Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS, McDonald TA (1991) Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci 48:69-75
27. Leza J-C, Lizasoain I, Cuéllar B, Moro MA, Lorenzo P (1996) Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmiedeberg's Arch Pharmacol 353:349-354
28. Majeed NH, Przewlocka B, Machelska H, Przewlocki R (1994) Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33:189-192
29. Malin DH, Murray JB, Crucian GP, Schweitzer FC, Cook RE, Skolnick MH (1988) Auricular microelectrostimulation:naloxone reversible attenuation of opiate abstinence syndrome. Biol Psychiatry 24:886-890
30. 2-like mammalian peptide precipitates opiate withdrawal syndrome in the rat. Peptides 11:277-280
31. 2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11:969-972
32. Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) A rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779-784
33. Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993b) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112:339-342
34. Malin DH, Lake JR, Arcangeli KR, Deshotel KD, Hausam DD, Witherspoon WE, Carter VA, Yang H-YT, Pal B, Burgess K (1993a) Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci 53: PL261-266
35. Malin DH, Lake JR, Carter VA, Cunningham JS, Hebert KM, Conrad DL, Wilson OB (1994) The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115:180-184
36. Malin DH, Lake JR, Smith DA, Jones JA, Morel J, Claunch AE, Stevens PA, Payza K, Ho K-K, Liu J, Ham I, Burgess K (1995) Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Drug Alcohol Depend 40:37-42
37. Malin DH, Lake JR, Payne MC, Short PE, Carter VA, Cunningham JS, Wilson OB (1996a) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacol Biochem Behav 53:81-85
38. Malin DH, Lake JR, Short PE, Blossman JB, Lawless BA, Schopen CK, Sailer EE, Burgess K, Wilson OB (1996b) Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. Pharmacol Biochem Behav 54:581-585
39. Malin DH, Lake JR, Schopen CK, Kirk JW, Sailer EE, Lawless BA, Upchurch TP, Shenoi M, Rajan N (1997) Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium. Pharmacol Biochem Behav 58:695-699
40. Malin DH, Lake JR, Upchurch TP, Shenoi M, Rajan N, Schweinle WE (1998) Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-β-erythroidine. Pharmacol Biochem Behav 60:609-613
41. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL (1993) 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108:296-297
42. Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81: 61-67
43. Raszkiewicz JL, Linville DG, Kerwin JF, Wagenaar F, Arneric SP (1992) Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. J Neurosci Res 33:129-135
44. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abdadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, Moncada S (1994) Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond 345:175-221
45. Rosecrans JA, Hendry JS, Hong JS (1985) Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacol Biochem Behav 23: 141-143
46. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50:35-39
47. Snyder SH (1992) Nitric oxide: first in a new class of neurotransmitters? Science 257:494-496
48. Suh HW, Hudson PM, McMillian MK, Das KP, Wilson BC, Wu GC, Hong JS (1995) Long-term stimulation of nicotinic receptors is required to increase proenkephalin A mRNA levels and the delayed secretion of [Met5]-enkephalin in bovine adrenal medullary chromaffin cells. J Pharmacol Exp Ther 275: 1663-1670
49. Takagi H, Shiomi H, Ueda H, Amano H (1979) A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser. Nature 282:410-412
50. G-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine dependent mice. Brain Res 642:153-159
51. Uzbay IT, Erden BF, Tapanyigit EE, Kayaalp SO (1997) Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61:2197-2209
52. Vaupel DB, Kimes AS, London ED (1995) Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology 118: 361-368
53. Vaupel DB, Kimes AS, London ED (1997) Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol 324:11-20
54. G-nitro-L-arginine contracts vascular smooth muscle by an endothelium-independent mechanism. J Cardiovasc Pharmacol 24:59-63
55. G-nitro-arginine in conscious rats are antagonized by L- but not D-arginine. Eur J Pharmacol 200: 77-81
56. G-nitro-arginine on endothelium-dependent relaxation of rat aorta. J Pharmacol Exp Ther 265:112-119
57. 2-opioid receptor agonist in mice. Peptides 17:619-623